BRD4 Inhibitor-33

• UNSPSC Description:

  BRD4 Inhibitor-33 (example 13) is a BRD4 inhibitor that can be used in acute kidney disease and chronic kidney disease research[1].

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/brd4-inhibitor-33.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=C(C(C3=C(OC4=CC=CC=C4)C=CC(CN5N=CC=C5)=C3)=CN1C)C=CN2

• Molecular Weight:

  396.44

• References & Citations:

  [1]Pyrrolopyridinone derivatives as bromodomain inhibitors and their preparation.World Intellectual Property Organization, et al. Pyrrolopyridinone derivatives as bromodomain inhibitors and their preparation.World Intellectual Property Organization, WO2013097601 A1 2013-07-04.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1445993-17-8